Cao W, Ma X, Hu W, Kou F, Liu Y, Nie J, Dai L, Zhang J, Fang J, Wang Y*. Incidence, Risk Factors, and Impact of Immunotherapy on Brain Metastasis in Extensive-Stage Small Cell Lung Cancer Without Baseline Brain Involvement.,JCO Oncol Pract.,2026 May 12:OP2501401

Liu Y, Liu J, Niu D, Hu L, Kou F, Jiao Y, Cao W, Liu Q, Fu X, Hu C, Tong J, Xiong H, Wang Y*. 16S rRNA gene sequencing reveals distinct intratumoral bacterial microbiome signatures between CT indeterminate benign and early-stage malignant pulmonary lesions.,Journal of Translational Medicine,2026 Apr 3;24(1):602.

Hu L, Pei Y, Wang X, Liu Q, Cao W, Liu Y, Kou F, Liao X, Zhang Y, Rui J, Tang J, Li S, Wang Y*. The frequency of core MMR gene alterations in lung cancer and their clinical characterization: A comprehensive study of over 26,000 cases.,The Innovation Medicine,2025, 3: 100163

Cao W, Kou F, Hu W, Hu L, Nie J, Dai L, Zhang J, Rui J, Knetki-Wróblewska M, Antonoff MB, Fang J, Wang Y*. First-line immunotherapy in advanced non-squamous non-small cell lung cancer patients with rare mutations: a retrospective cohort study.,Translational Lung Cancer Research.,2025 Jul 31;14（7）:2788–2798.

肺癌的免疫与靶向治疗，肿瘤微环境，新药研发

非小细胞肺癌新辅助治疗后non-pCR患者基于分子分型预测高复发风险人群, 课题负责人, 2025.1.1～2027.12.31, 北京市研究型病房卓越计划平行项目

错配修复基因缺陷在非小细胞肺癌中的临床应用价值研究, 课题负责人, 2025.1.1～2027.12.31, 北京市医院管理中心“培育计划”

基于机器学习与代谢组学的非小细胞肺癌免疫联合化疗疗效预测研究, 课题负责人, 2026.1.1～2027.12.31, 北京大学肿瘤医院科学研究基金学科交叉项目

EGFR突变肺癌中Trop-2抗体偶联药物（ADC）响应及耐药机制研究, 课题负责人, 2026.1.1～2027.12.31, 北京肿瘤防治研究会CAPTRA-STAR科研基金项目